3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
5
Recurrence
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma
2
Immunoblastic Lymphadenopathy
2
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
pembrolizumab
29
Cisplatin
18
Carboplatin
14
Cetuximab
12
Radiotherapy
10
Paclitaxel
10
Surveys and Questionnaires
8
Docetaxel
6
Radiotherapy, Intensity-Modulated
5
Surgical Procedures, Operative
4
Standard of Care
4
Fluorouracil
4
Chemoradiotherapy
4
dostarlimab
3
Therapeutics
3
Nivolumab
3
Cyclophosphamide
3
Blood Specimen Collection
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
tislelizumab
2
nimotuzumab
2
fludarabine
2
durvalumab
2
cemiplimab
2
atezolizumab
2
abemaciclib
2
X-Rays
2
Taxes
2
Radiosurgery
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
duvelisib
×
90 days
×
Clear all
No trials found.